Covid-19 Research

Research Article

Comparative Study of the Reactivity of Animal-Derived Blood on Medical Device Materials using Hematology and Platelet Activity Tests

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Research Article
Subject Biology Group
OCLC JBRES Record
Jeonghwa Kim, Geonyong Kim, Sekyung Kim, Joonho Eom and Taewon Kim*
Issue: Volume5-Issue7
Pages: 779-786
Received: 2024-07-12
Accepted: 2024-07-17
Published: 2024-07-18

Abstract

In accordance with the requirements of ISO 10993-4, we established the feasibility of conditions for animal blood application in vitro to identify substances that induce thrombus formation and confirmed the differences in blood reactivity between animals necessary for interpreting in vivo results in this study. To this end, differences in the response of rabbit, pig, and monkey blood to each anticoagulant presented in ASTM F2888-19 were tested.

It was confirmed that the direct heparinization method had a higher test sensitivity than that of recalcified sodium citrate, thus distinguishing thrombotic substances regardless of the test species. Particularly in pig blood, platelet and white blood cell counts showed the greatest decrease after reactions with various test materials.

Expression of β-TG and PMN-elastase, indicators for platelet and leukocyte activities, was confirmed in pig blood when reacted with various test materials. A decrease in platelet count and significant increase in β-TG were observed in the black rubber test group, which was the positive candidate material. Conversely, a decreased leukocyte count was confirmed, but an increase in the expression of PMN-elastase was not observed. This result satisfied the ISO 10993-4 criteria for determining a positive thromboembolic substance.

This study provided additional information on the selection of anticoagulants for the design of trials and selection of animal species for evaluating thrombosis formation on medical device materials by using the methods described in ISO 10993-4 and ASTM F2888-19.

FullText HTML FullText PDF DOI: 10.37871/jbres1955 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2024 Kim J, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Kim J, Kim G, Kim S, Eom J, Kim T. Comparative Study of the Reactivity of Animal-Derived Blood on Medical Device Materials using Hematology and Platelet Activity Tests. J Biomed Res Environ Sci. 2024 Jul 18; 5(7): 779-786. doi: 10.37871/jbres1955, Article ID: JBRES1955, Available at: https://www.jelsciences.com/articles/jbres1955.pdf

Subject area(s)

BiologyBiomedical Science

References

  1. Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process. Arlington, VA: The International Organization for Standardization (ISO). 2018;10993-1.
  2. Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood. Arlington, VA: The International Organization for Standardization (ISO). 2017;10993-4:
  3. Standard practice for platelet leukocyte count-an in-vitro measure for hemocompatibility assessment of cardiovascular materials. West Conshohocken, PA: ASTM International. 2019;F2888-19.
  4. Standard test method for platelet leukocyte count-an in-vitro measure for hemocompatibility assessment of cardiovascular materials. West Conshohocken, PA: ASTM International. 2013;F2888-13
  5. Lu Q, Nehrer JM, Li J, Jamiolkowski MA, Rinaldi JE, Malinauskas RA. Platelet and leukocyte count assay for thrombogenicity screening of biomaterials and medical devices: Evaluation and improvement of ASTM F2888 test standard. J Biomed Mater Res B Appl Biomater. 2021 Dec;109(12):2259-2267. doi: 10.1002/jbm.b.34887. Epub 2021 Jun 9. PMID: 34106517; PMCID: PMC8490275.
  6. Lu Q, Nehrer J, Malinauskas R. Platelet and leukocyte counts as hemocompatibility indicators for biomaterials: An evaluation of ASTM standard test method F2888-13. Paper presented at: Transactions of the 39th Annual Society for Biomaterials. Charlotte, NC: Omnipress. 2015;57.
  7. Jaffer IH, Fredenburgh JC, Hirsh J, Weitz JI. Medical device-induced thrombosis: what causes it and how can we prevent it? J Thromb Haemost. 2015 Jun;13 Suppl 1:S72-81. doi: 10.1111/jth.12961. PMID: 26149053.
  8. Kerry PJ, Curtis AD. Standardization of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4): a collaborative study to establish international standards for beta-TG and PF4. Thromb Haemost. 1985 Feb 18;53(1):51-5. PMID: 2581331.
  9. Swars H, Hafner G, Weilemann LS, Ehrenthal W, Schinzel H, Prellwitz W, Meyer J. Acute dialysis: PMN-elastase as a new parameter for controlling individual anticoagulation with low molecular weight heparin (Fragmin). Intensive Care Med. 1991;17(1):52-6. doi: 10.1007/BF01708410. PMID: 1645379.
  10. Brandt E, Petersen F, Ludwig A, Ehlert JE, Bock L, Flad HD. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation. J Leukoc Biol. 2000 Apr;67(4):471-8. doi: 10.1002/jlb.67.4.471. PMID: 10770278.
  11. Fröhlich E. Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation. Curr Med Chem. 2016;23(5):408-30. doi: 10.2174/0929867323666160106151428. PMID: 26063498; PMCID: PMC5403968.
  12. Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Fröhlich E. The role of nanoparticle size in hemocompatibility. Toxicology. 2009 Apr 28;258(2-3):139-47. doi: 10.1016/j.tox.2009.01.015. Epub 2009 Jan 22. PMID: 19428933.
  13. Teligui L, Dalmayrac E, Corbeau JJ, Bouquet E, Godon A, Denommé AS, Binuani P, Verron L, Boer C, Baufreton C. Ex vivo simulation of cardiopulmonary bypass with human blood for hemocompatibility testing. Perfusion. 2016 Jul;31(5):376-83. doi: 10.1177/0267659115599454. Epub 2015 Aug 4. PMID: 26243277.
  14. Stoll H, Steinle H, Stang K, Kunnakattu S, Scheideler L, Neumann B, Kurz J, Degenkolbe I, Perle N, Schlensak C, Wendel HP, Avci-Adali M. Generation of Large-Scale DNA Hydrogels with Excellent Blood and Cell Compatibility. Macromol Biosci. 2017 Apr;17(4). doi: 10.1002/mabi.201600252. Epub 2016 Oct 19. PMID: 27758025.
  15. Zimmermann AK, Weber N, Aebert H, Ziemer G, Wendel HP. Effect of biopassive and bioactive surface-coatings on the hemocompatibility of membrane oxygenators. J Biomed Mater Res B Appl Biomater. 2007 Feb;80(2):433-9. doi: 10.1002/jbm.b.30614. PMID: 16850460.
  16. Warren HB, Lausen NC, Segre GV, el-Hajj G, Brown EM. Regulation of calciotropic hormones in vivo in the New Zealand white rabbit. Endocrinology. 1989 Nov;125(5):2683-90. doi: 10.1210/endo-125-5-2683. PMID: 2507295.
  17. Harcourt-Brown F. Clinical pathology. Textbook of Rabbit Medicine. 2002;140-164.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership